Skip to content

Country

Covidien Monoject Blood Collection Tube 2 ml 10.25 mm x 50 mm 2 Packs of 100 Tubes Each

Availability:
Only 1 left!
SKU 10812
Save 13% Save 13%
Original price $92.00
Original price $92.00 - Original price $92.00
Original price $92.00
Current price $80.00
$80.00 - $80.00
Current price $80.00

Monoject™ 2 mL Red Stopper Blood Collection Tubes (8881301116) – Lot of 200 Tubes

The Monoject™ 8881301116 standard blood collection tubes (now manufactured under the Cardinal Health portfolio, formerly Covidien) are elite vacuum-sealed laboratory vessels optimized for routine serum chemistry, serology testing, and clinical sample processing. Measuring 10.25 mm x 50 mm with a 2 mL draw volume, these high-purity glass tubes feature a no-additive, silicone-coated interior that promotes clean clotting without interfering with serum components. Outfitted with a specialized glycerine-coated conventional red stopper, this lot of 200 tubes ensures stable vacuum retention and leak-free centrifugation transitions.

Technical Performance & Design

  • No-Additive Pure Serum Chemistry: Formulated completely free of anticoagulants or clot activators, allowing the natural coagulation cascade to proceed natively for clear, unaltered serum extractions.
  • Silicone-Coated Interior Walls: Inner glass boundaries are treated with a water-soluble micro-layer of silicone, reducing red blood cell adhesion to the walls, accelerating clot retraction, and minimizing hemolysis risks during centrifuge spins.
  • Glycerine-Coated Rubber Closure: Equipped with a tight-fitting red conventional stopper treated with a glycerine film lubrication layer. This layer ensures smooth manual or automated decapping while maintaining a hermetic vacuum seal over long shelf lives.
  • Premium Glass Geometry: Fabricated from heavy-walled, high-clarity glass capable of handling intensive relative centrifugal forces (RCF) inside standard swing-bucket or fixed-angle clinical rotors.

Product Specifications

  • Model Number / SKU: 8881301116 (Monoject™ Standard Series)
  • Primary Manufacturer: Cardinal Health (Formerly Covidien / Kendall Life Sciences)
  • Tube Dimensional Metrics: 10.25 mm Diameter x 50 mm Length
  • Nominal Draw Volume: 2.0 mL Capacity
  • Additive Formulations: None (Plain Tube Matrix)
  • Surface Treatment: Silicone-Coated Interior Channel
  • Stopper Variant & Coding: Conventional Red Rubber Stopper (Glycerine Coated)
  • Sterility Status: Certified sterile tube and stopper interior via validated gamma radiation protocols
  • Packaging Configuration: Lot of 200 Tubes (Comprising 2 internal vacuum-sealed packs of 100 tubes each; standard factory master cases are distributed under 8881301116 as 10 packs of 100 for a total case count of 1000).

Key Benefits & Applications

  • Routine Serum Chemistry Analysis: Serves as an ideal raw substrate container for blood panels requiring clear serum, including metabolic profiles, liver function panels, lipid tracking, and drug monitoring assays.
  • Serology and Immunology Processing: The absence of anticoagulant chemicals blocks interference during antibody screenings, antigen test validations, and blood bank cross-matching procedures.
  • Reliable Vacuum Draw Matrix: Precision-calibrated internal negative pressure ensures an exact 2 mL fluid draw upon venipuncture needle connection, preventing overfill variables or sample dilution shifts.
  • Aseptic Transfer Maintenance: The sterile interior environment prevents the introduction of external microbial contaminants, preserving specimen integrity during transport to central testing facilities.

Monoject™ and CELLSTAR® are commercial trademarks of Cardinal Health and its affiliated groups. Catalog item 8881301116 indicates the plain glass red-stopper configuration. For hematology testing requiring whole-blood or plasma stabilization, alternative lavender-top EDTA (K3) or green-top Lithium Heparin tubes must be used instead.

Please note that Life Sciences Trading is not a factory-authorized distributor of the products listed in this store. The items have been acquired as surplus from leading life sciences companies.